Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease

Parkinson's Disease

Volumn , Issue , 2011, Pages

  Farooqui, Tahira ^a   Farooqui, Akhlaq A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ALPHA SYNUCLEIN; CYTOKINE; GLUTATHIONE; INTERLEUKIN 1BETA; ISOPROSTANE; LIPID; PROSTAGLANDIN; PROTEASOME; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

CELL ACTIVATION; CORPUS STRIATUM; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; EVIDENCE BASED PRACTICE; HUMAN; INFLAMMATION; MICROGLIA; MITOCHONDRION; MORBIDITY; NITROSATIVE STRESS; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPLETION; REVIEW; SUBSTANTIA NIGRA;

EID: 79953272320     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2011/247467     Document Type: Review

References (59)

1. Beal M. F., Mitochondrial dysfunction in neurodegenerative diseases Biochimica et Biophysica Acta 1998 1366 1-2 211 223 (Pubitemid 28467033)
2. Jenner P., Olanow C. W., The pathogenesis of cell death in Parkinson's disease Neurology 2006 66 10, supplement 4 S24 S36
3. Farrer M. J., Haugarvoll K., Ross O. A., Stone J. T., Milkovic N. M., Cobb S. A., Whittle A. J., Lincoln S. J., Hulihan M. M., Heckman M. G., White L. R., Aasly J. O., Gibson J. M., Gosal D., Lynch T., Wszolek Z. K., Uitti R. J., Toft M., Genomewide association, Parkinson disease, and PARK10 American Journal of Human Genetics 2006 78 6 1084 1088 (Pubitemid 43787702)
4. Lcking C. B., Drr A., Bonifati V., Vaughan J., De Michele G., Gasser T., Harhangi B. S., Meco G., Denfle P., Wood N. W., Agid Y., Brice A., Nicholl D., Breteler M. M. B., Oostra B. A., De Mari M., Marconi R., Filla A., Bonnet A. -M., Broussolle E., Pollak P., Rascol O., Rosier M., Arnould I., Association between early-onset Parkinson's disease and mutations in the parkin gene New England Journal of Medicine 2000 342 21 1560 1567 (Pubitemid 30340501)
5. Farooqui A. A., Neurochemical Aspects of Neuroinflammation in Brain in Molecular Aspects of Neurodegeneration and Neuroprotection 2010 Oak Park, Ill, USA Bentham Science. A. A. Farooqui and T. Farooqui, Eds
6. Wang C., Liu L., Zhang L., Peng Y., Zhou F., Redox reactions of the -synuclein- Cu2+ complex and their effects on neuronal cell viability Biochemistry 2010 49 37 8134 8142
7. Halliwell B., Oxidative stress and neurodegeneration: where are we now? Journal of Neurochemistry 2006 97 6 1634 1658 (Pubitemid 43873658)
8. Sun G. Y., Horrocks L. A., Farooqui A. A., The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases Journal of Neurochemistry 2007 103 1 1 16 (Pubitemid 47404193)
9. Farooqui A. A., Ong W. Y., Horrocks L. A., Neurochemical Aspects of Excitotoxicity 2008 New York, NY, USA Springer
10. Farooqui A. A., Horrocks L. A., Glycerophospholipids in Brain 2007 New York, NY, USA Springer
11. Valko M., Morris H., Cronin M. T. D., Metals, toxicity and oxidative stress Current Medicinal Chemistry 2005 12 10 1161 1208 (Pubitemid 40655271)
12. Farooqui A. A., Neurochemical Aspects of Neurotraumatic and Neurodegenerative Disease 2010 New York, NY, USA Springer
13. Fernstrom J. D., Effects of dietary polyunsaturated fatty acids on neuronal function Lipids 1999 34 2 161 169 (Pubitemid 29138313)
14. Buisson A., Lakhmeche N., Verrecchia C., Plotkine M., Boulu R. G., Nitric oxide: an endogenous anticonvulsant substance NeuroReport 1993 4 4 444 446 (Pubitemid 23116745)
15. Jenkinson A. M., Collins A. R., Duthie S. J., Wahle K. W. J., Duthie G. G., The effect of increased intakes of polyunsaturated fatty acids and vitamin E on DNA damage in human lymphocytes FASEB Journal 1999 13 15 2138 2142
16. Shibata N., Kobayashi M., The role for oxidative stress in neurodegenerative diseases Brain and Nerve 2008 60 2 157 170 (Pubitemid 351263007)
17. Lipton S. A., Gu Z., Nakamura T., Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders International Review of Neurobiology 2007 82 1 27
18. Nakamura T., Lipton S. A., Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases Antioxidants and Redox Signaling 2008 10 1 87 101 (Pubitemid 350115990)
19. Ebadi M., Sharma S. K., Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease Antioxidants and Redox Signaling 2003 5 3 319 335 (Pubitemid 36793015)
20. Branco D. M., Arduino D. M., Esteves A. R., Silva D. F., Cardoso S. M., Oliveira C. R., Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis Frontiers in Aging Neuroscience 2010 2, article 17
21. Atlante A., Calissano P., Bobba A., Azzariti A., Marra E., Passarella S., Cytochrome c is released from mitochondria in a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic death Journal of Biological Chemistry 2000 275 47 37159 37166 (Pubitemid 32002134)
22. Dronne M. A., Grenier E., Dumont T., Hommel M., Boissel J. P., Role of astrocytes in grey matter during stroke: a modelling approach Brain Research 2007 1138 1 231 242
23. Khan F. H., Sen T., Maiti A. K., Jana S., Chatterjee U., Chakrabarti S., Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease Biochimica et Biophysica Acta 2005 1741 1-2 65 74 (Pubitemid 40824991)
24. Bisaglia M., Soriano M. E., Arduini I., Mammi S., Bubacco L., Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease Biochimica et Biophysica Acta 2010 1802 9 699 706
25. Klivenyi P., Beal M. F., Ferrante R. J., Andreassen O. A., Wermer M., Chin MI. R., Bonventre J. V., Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity Journal of Neurochemistry 1998 71 6 2634 2637 (Pubitemid 28531277)
26. Singer T. P., Castagnoli N. Jr., Ramsay R. R., Trevor A. J., Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine Journal of Neurochemistry 1987 49 1 1 8 (Pubitemid 17108222)
27. Tariq M., Khan H. A., Moutaery K. A., Deeb S. A., Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents Brain Research Bulletin 2001 54 1 77 82 (Pubitemid 32156918)
28. Yoshinaga N., Yasuda Y., Murayama T., Nomura Y., Possible involvement of cytosolic phospholipase A2 in cell death induced by 1-methyl-4-phenylpyridinium ion, a dopaminergic neurotoxin, in GH3 cells Brain Research 2000 855 2 244 251 (Pubitemid 30085496)
29. Feng Z., Li D., Fung P. C. W., Pei Z., Ramsden D. B., Ho S. L., COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice NeuroReport 2003 14 15 1927 1929 (Pubitemid 38339762)
30. Teismann P., Vila M., Choi D. K., Tieu K., Wu D. C., Jackson-Lewis V., Przedborski S., COX-2 and neurodegeneration in Parkinson's disease Annals of the New York Academy of Sciences 2003 991 272 277 (Pubitemid 36793820)
31. Wood P. L., Neuroinflammation: Mechanisms and Managements 1998 Totowa, NJ, USA Humana Press
32. Seet R. C. S., Lee C. Y. J., Lim E. C. H., Tan J. J. H., Quek A. M. L., Chong W. L., Looi W. F., Huang S. H., Wang H., Chan Y. H., Halliwell B., Oxidative damage in Parkinson disease: measurement using accurate biomarkers Free Radical Biology and Medicine 2010 48 4 560 566
33. Beler H., Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease Experimental Neurology 2009 218 2 235 246
34. Beyer K., Mechanistic aspects of Parkinson's disease: -synuclein and the biomembrane Cell Biochemistry and Biophysics 2007 47 2 285 299 (Pubitemid 47338366)
35. Ghosh A., Roy A., Liu X., Kordower J. H., Mufson E. J., Hartley D. M., Ghosh S., Mosley R. L., Gendelman H. E., Pahan K., Selective inhibition of NF- B activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18754 18759 (Pubitemid 350210769)
36. Sawada M., Imamura K., Nagatsu T., Role of cytokines in inflammatory process in Parkinson's disease Journal of Neural Transmission, Supplement 2006 70 373 381 (Pubitemid 44622226)
37. Nagatsu T., Sawada M., Inflammatory process in Parkinson's disease: role for cytokines Current Pharmaceutical Design 2005 11 8 999 1016 (Pubitemid 40331301)
38. Nagatsu T., Mogi M., Ichinose H., Togari A., Changes in cytokines and neurotrophins in Parkinson's disease Journal of Neural Transmission, Supplement 2000 60 277 290 (Pubitemid 32037200)
39. Calabrese V., Cornelius C., Rizzarelli E., Owen J. B., Dinkova-Kostova A. T., Butterfield D. A., Nitric oxide in cell survival: a janus molecule Antioxidants Redox Signaling 2009 11 11 2717 2739
40. Nakamura T., Lipton S. A., S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Antioxidants and Redox Signaling. In press
41. Tsang A. H. K., Chung K. K. K., Oxidative and nitrosative stress in Parkinson's disease Biochimica et Biophysica Acta 2009 1792 7 643 650
42. Chung K. K. K., Thomas B., Li X., Pletnikova O., Troncoso J. C., Marsh L., Dawson V. L., Dawson T. M., S-nitrosylation of parkin regulates ubiquitination and compromises Parkin's protective function Science 2004 304 5675 1328 1331 (Pubitemid 38697430)
43. Correale J., Villa A., The neuroprotective role of inflammation in nervous system Injuries Journal of Neurology 2004 251 11 1304 1316
44. Farooqui A. A., Horrocks L. A., Farooqui T., Modulation of inflammation in brain: a matter of fat Journal of Neurochemistry 2007 101 3 577 599 (Pubitemid 46633316)
45. Hirsch E. C., Hunot S., Neuroinflammation in Parkinson's disease: a target for neuroprotection? The Lancet Neurology 2009 8 4 382 397
46. Long-Smith C. M., Sullivan A. M., Nolan Y. M., The influence of microglia on the pathogenesis of Parkinson's disease Progress in Neurobiology 2009 89 3 277 287
47. Tansey M. G., Goldberg M. S., Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention Neurobiology of Disease 2010 37 3 510 518
48. Serhan C. N., Savill J., Resolution of inflammation: the beginning programs the end Nature Immunology 2005 6 12 1191 1197 (Pubitemid 43045627)
49. Farooqui A. A., Horrocks L. A., Farooqui T., Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide Journal of Neuroscience Research 2007 85 9 1834 1850 (Pubitemid 47051473)
50. Amor S., Puentes F., Baker D., van der Valk P., Inflammation in neurodegenerative diseases Immunology 2010 129 2 154 169
51. Wilson C. J., Finch C. E., Cohen H. J., Cytokines and cognitionthe case for a head-to-toe inflammatory paradigm Journal of the American Geriatrics Society 2002 50 12 2041 2056 (Pubitemid 35462453)
52. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X. F., Achong M. K., IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses Journal of Clinical Investigation 1998 101 2 311 320 (Pubitemid 28067327)
53. Sulzer D., Bogulavsky J., Larsen K. E., Behr G., Karatekin E., Kleinman M. H., Turro N., Krantz D., Edwards R. H., Greene L. A., Zecca L., Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles Proceedings of the National Academy of Sciences of the United States of America 2000 97 22 11869 11874
54. Paris I., Lozano J., Perez-Pastene C., Muoz P., Segura-Aguilar J., Molecular and neurochemical mechanisms in PD pathogenesis Neurotoxicity Research 2009 16 3 271 279
55. Gerlach M., Riederer P., Double K. L., Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease Parkinsonism and Related Disorders 2008 14 supplement 2 S185 S188
56. Wilms H., Zecca L., Rosenstiel P., Sievers J., Deuschl G., Lucius R., Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications Current Pharmaceutical Design 2007 13 18 1925 1928 (Pubitemid 47017994)
57. Zecca L., Wilms H., Geick S., Claasen J. H., Brandenburg L. O., Holzknecht C., Panizza M. L., Zucca F. A., Deuschl G., Sievers J., Lucius R., Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease Acta Neuropathologica 2008 116 1 47 55
58. Tansey M. G., Goldberg M. S., Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention Neurobiology of Disease 2010 37 3 510 518
59. Zhang W., Phillips K., Wielgus A. R., Liu J., Albertini A., Zucca F. A., Faust R., Qian S. Y., Miller D. S., Chignell C. F., Wilson B., Jackson-Lewis V., Przedborski S., Joset D., Loike J., Hong J. -S., Sulzer D., Zecca L., Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease Neurotoxicity Research 2011 19 1 63 72